T. Thomsen

1.7k total citations
29 papers, 1.3k citations indexed

About

T. Thomsen is a scholar working on Pharmacology, Organic Chemistry and Pharmacology. According to data from OpenAlex, T. Thomsen has authored 29 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmacology, 8 papers in Organic Chemistry and 8 papers in Pharmacology. Recurrent topics in T. Thomsen's work include Cholinesterase and Neurodegenerative Diseases (12 papers), Chemical synthesis and alkaloids (8 papers) and Pharmacogenetics and Drug Metabolism (7 papers). T. Thomsen is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (12 papers), Chemical synthesis and alkaloids (8 papers) and Pharmacogenetics and Drug Metabolism (7 papers). T. Thomsen collaborates with scholars based in Germany, United States and Netherlands. T. Thomsen's co-authors include H. Kewitz, Ulrich Bickel, Gerd Mikus, Jürgen Burhenne, Walter E. Haefeli, Jens Rengelshausen, K. Riedel, Willi Weber, R. Bachus and Ivar Roots and has published in prestigious journals such as Journal of Clinical Oncology, Biochemical Pharmacology and Life Sciences.

In The Last Decade

T. Thomsen

29 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. Thomsen Germany 18 584 316 307 253 161 29 1.3k
J. B. Fourtillan France 21 451 0.8× 232 0.7× 52 0.2× 127 0.5× 164 1.0× 68 1.7k
Gilbert Lefèvre Switzerland 21 350 0.6× 136 0.4× 76 0.2× 272 1.1× 107 0.7× 52 1.5k
Shue‐Ling Raung Taiwan 27 168 0.3× 597 1.9× 87 0.3× 135 0.5× 239 1.5× 40 1.8k
J. Girault France 19 147 0.3× 178 0.6× 47 0.2× 115 0.5× 126 0.8× 47 1.2k
Jiang Ting-liang China 18 297 0.5× 563 1.8× 67 0.2× 200 0.8× 63 0.4× 41 1.4k
A. De Sarro Italy 19 300 0.5× 341 1.1× 185 0.6× 45 0.2× 84 0.5× 45 1.3k
Eckhard Beubler Austria 26 257 0.4× 706 2.2× 30 0.1× 153 0.6× 284 1.8× 88 2.2k
Weibin Zha China 25 174 0.3× 789 2.5× 21 0.1× 229 0.9× 87 0.5× 48 1.5k
Marvin E. Rosenthale United States 18 441 0.8× 207 0.7× 170 0.6× 111 0.4× 81 0.5× 53 1.1k
Hajime Kotaki Japan 21 273 0.5× 348 1.1× 22 0.1× 472 1.9× 122 0.8× 91 1.5k

Countries citing papers authored by T. Thomsen

Since Specialization
Citations

This map shows the geographic impact of T. Thomsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Thomsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Thomsen more than expected).

Fields of papers citing papers by T. Thomsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Thomsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Thomsen. The network helps show where T. Thomsen may publish in the future.

Co-authorship network of co-authors of T. Thomsen

This figure shows the co-authorship network connecting the top 25 collaborators of T. Thomsen. A scholar is included among the top collaborators of T. Thomsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Thomsen. T. Thomsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kam, Pieter‐Jan de, et al.. (2010). Effects of Sugammadex Doses up to 32 mg/kg Alone or in Combination with Rocuronium or Vecuronium on QTc Prolongation. Clinical Drug Investigation. 30(9). 599–611. 38 indexed citations
3.
Schnabel, Peter, et al.. (2007). The effect of food composition on serum testosterone levels after oral administration of Andriol® Testocaps®. Clinical Endocrinology. 66(4). 579–585. 46 indexed citations
4.
Goss, Paul E., et al.. (2007). Effects of steroidal and nonsteroidal aromatase inhibitors on markers of bone turnover in healthy postmenopausal women. Breast Cancer Research. 9(4). R52–R52. 68 indexed citations
5.
Mikus, Gerd, Jens Rengelshausen, Ru Ding, et al.. (2006). Potent cytochrome P450 2C19 genotype–related interaction between voriconazole and the cytochrome P450 3A4 inhibitor ritonavir. Clinical Pharmacology & Therapeutics. 80(2). 126–135. 126 indexed citations
6.
Rengelshausen, Jens, K. Riedel, Jürgen Burhenne, et al.. (2005). Opposite effects of short-term and long-term St John’s wort intake on voriconazole pharmacokinetics. Clinical Pharmacology & Therapeutics. 78(1). 25–33. 105 indexed citations
7.
Dogterom, Peter, Michiel W. van den Heuvel, & T. Thomsen. (2005). Absence of Pharmacokinetic Interactions of the Combined Contraceptive Vaginal Ring NuvaRing?? with Oral Amoxicillin or Doxycycline in Two Randomised Trials. Clinical Pharmacokinetics. 44(4). 429–438. 19 indexed citations
8.
Vollmar, Jens, T. Thomsen, Luis Mateo, et al.. (2005). Safety and immunogenicity of IMVAMUNE, a promising candidate as a third generation smallpox vaccine. Vaccine. 24(12). 2065–2070. 127 indexed citations
9.
BROCKMOLLER, J, T. Thomsen, Matthias Wittstock, et al.. (2005). Pharmacokinetics of levetiracetam in patients with moderate to severe liver cirrhosis (Child-Pugh classes A, B, and C): Characterization by dynamic liver function tests. Clinical Pharmacology & Therapeutics. 77(6). 529–541. 47 indexed citations
10.
Subar, Milayna, et al.. (2004). Effects of steroidal and nonsteroidal aromatase inhibitors (AIs) on markers of bone turnover and lipid metabolism in healthy volunteers. Journal of Clinical Oncology. 22(14_suppl). 8038–8038. 19 indexed citations
11.
Püchler, Kurt, Katja‐Martina Eckl, Lutz Fritsche, et al.. (1997). Pharmacokinetics of temocapril and temocaprilat after 14 once daily oral doses of temocapril in hypertensive patients with varying degrees of renal impairment. British Journal of Clinical Pharmacology. 44(6). 531–536. 5 indexed citations
12.
Höll, G., et al.. (1992). Effect of the cholinesterase inhibiting substance galanthamine on human EEG and visual evoked potentials. Electroencephalography and Clinical Neurophysiology. 82(6). 445–452. 24 indexed citations
13.
Köppel, Claus, T. Thomsen, Gerhard Heinemeyer, & I Roots. (1991). Acute Poisoning With Bromofosmethyl (Bromophos). Journal of Toxicology Clinical Toxicology. 29(2). 203–207. 5 indexed citations
14.
Bickel, Ulrich, et al.. (1991). Pharmacokinetics of galanthamine in humans and corresponding cholinesterase inhibition. Clinical Pharmacology & Therapeutics. 50(4). 420–428. 75 indexed citations
15.
Thomsen, T., et al.. (1991). In vitro effects of various cholinesterase inhibitors on acetyl- and butyrylcholinesterase of healthy volunteers. Biochemical Pharmacology. 41(1). 139–141. 68 indexed citations
16.
Bickel, Ulrich, et al.. (1991). Galanthamine: pharmacokinetics, tissue distribution and cholinesterase inhibition in brain of mice. Neuropharmacology. 30(5). 447–454. 54 indexed citations
17.
Thomsen, T., et al.. (1991). Inhibition of Acetylcholinesterase Activity in Human Brain Tissue and Erythrocytes by Galanthamine, Physostigmine and Tacrine. Clinical Chemistry and Laboratory Medicine (CCLM). 29(8). 487–92. 77 indexed citations
18.
Thomsen, T. & H. Kewitz. (1990). Selective inhibition of human acetylcholinesterase by galanthamine in vitro and in vivo. Life Sciences. 46(21). 1553–1558. 169 indexed citations
19.
20.
Thomsen, T., et al.. (1988). Estimation of Cholinesterase Activity (EC 3.1.1.7; 3.1.1.8) in Undiluted Plasma and Erythrocytes as a Tool for Measuring In Vivo Effects of Reversible Inhibitors. Clinical Chemistry and Laboratory Medicine (CCLM). 26(7). 469–75. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. B. Fourtillan Breakdown of academic impact, for papers by Gilbert Lefèvre Breakdown of academic impact, for papers by Shue‐Ling Raung Breakdown of academic impact, for papers by J. Girault Breakdown of academic impact, for papers by Jiang Ting-liang Breakdown of academic impact, for papers by A. De Sarro Breakdown of academic impact, for papers by Eckhard Beubler Breakdown of academic impact, for papers by Weibin Zha Breakdown of academic impact, for papers by Marvin E. Rosenthale Breakdown of academic impact, for papers by Hajime Kotaki
Rankless by CCL
2026